The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

Rejeski, Kai; Perez, Ariel; Iacoboni, Gloria; Penack, Olaf; Bucklein, Veit; Jentzsch, Liv; Mougiakakos, Dimitrios; Johnson, Grace; Arciola, Brian; Carpio, Cecilia; Blumenberg, Viktoria; Hoster, Eva; Bullinger, Lars; Locke, Frederick L.; Von Bergwelt-Baildon, Michael; Mackensen, Andreas; Bethge, Wolfgang; Barba, Pere; Jain, Michael D.; Subklewe, Marion

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

Author:

Rejeski, Kai; Perez, Ariel; Iacoboni, Gloria; Penack, Olaf; Bucklein, Veit; Jentzsch, Liv; Mougiakakos, Dimitrios; Johnson, Grace; Arciola, Brian; Carpio, Cecilia; Blumenberg, Viktoria; Hoster, Eva; Bullinger, Lars; Locke, Frederick L.; Von Bergwelt-Baildon, Michael; Mackensen, Andreas; Bethge, Wolfgang; Barba, Pere; Jain, Michael D.; Subklewe, Marion

Tübinger Autor(en):

Jentzsch, Liv
Bethge, Wolfgang Andreas

Published in:

Journal For Immunotherapy of Cancer (2022), Bd. 10 (5), Article e004475

Verlagsangabe:

Bmj Publishing Group

Language:

English

Full text:

http://dx.doi.org/10.1136/jitc-2021-004475

ISSN:

2051-1426